DexCom Inc (DXCM)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$90.25
Buy
$92.47
$1.97 (+2.22%)
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
Prices updated at 24 Feb 2025, 11:14 EST
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) | Operating margin (%) | Net margin (%) | EBITDA margin (%) | EBITDA |
---|---|---|---|---|---|
2024 | 60.46 | 14.88 | 14.29 | 23.45 | 946m |
2023 | 63.19 | 16.50 | 14.95 | 25.31 | 917m |
2022 | 64.72 | 13.44 | 11.73 | 19.43 | 565m |
2021 | 68.63 | 10.86 | 8.86 | 15.42 | 378m |
2020 | 66.44 | 15.54 | 25.62 | 19.56 | 377m |
2019 | 63.11 | 9.64 | 6.85 | 14.44 | 213m |
2018 | 64.36 | -18.06 | -12.32 | -7.24 | -75m |
2017 | 68.49 | -5.92 | -6.99 | -2.74 | -20m |
2016 | 66.00 | -11.15 | -11.44 | -8.58 | -49m |
Valuation data table
Year | Price / Sales | Price earnings | Price / Cash flow |
---|---|---|---|
2025 | 9.29 | 63.91 | 37.85 |
2024 | 8.17 | 47.13 | 39.31 |
2023 | 15.60 | 136.36 | 71.01 |
2022 | 16.24 | 253.05 | 70.55 |
2021 | 23.08 | 99.99 | 105.21 |
2020 | 19.46 | 151.52 | 79.21 |
2019 | 14.63 | - | 96.67 |
2018 | 11.62 | 249.58 | 81.30 |
2017 | 7.36 | - | 76.73 |
2016 | 9.28 | - | 91.28 |
2015 | 18.10 | - | 139.59 |
Price/Forward earnings (YTD)
45.45
Returns
Debt profile
Returns data table
Year | Return on assets (%) | Return on equity (%) | Return on invested capital (%) |
---|---|---|---|
2024 | 9.04 | 27.63 | 10.32 |
2023 | 9.29 | 25.78 | 10.16 |
2022 | 6.61 | 16.35 | 7.94 |
2021 | 4.70 | 11.21 | 5.78 |
2020 | 14.77 | 36.44 | 19.05 |
2019 | 4.69 | 13.08 | 7.17 |
2018 | -9.01 | -23.48 | -9.22 |
2017 | -7.68 | -14.28 | -8.91 |
2016 | -18.88 | -25.98 | -25.15 |
Debt profile data table
Year | Financial leverage |
---|---|
2024 | 3.08 |
2023 | 3.03 |
2022 | 2.53 |
2021 | 2.42 |
2020 | 2.35 |
2019 | 2.71 |
2018 | 2.89 |
2017 | 2.16 |
2016 | 1.42 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.